↓ Skip to main content

Dove Medical Press

Article Metrics

Illicit methylphenidate use among Iranian medical students: prevalence and knowledge

Overview of attention for article published in Drug Design, Development and Therapy, February 2011
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

blogs
1 blog
policy
1 policy source
twitter
2 tweeters

Citations

dimensions_citation
43 Dimensions

Readers on

mendeley
101 Mendeley
Title
Illicit methylphenidate use among Iranian medical students: prevalence and knowledge
Published in
Drug Design, Development and Therapy, February 2011
DOI 10.2147/dddt.s13818
Pubmed ID
Authors

Kamyar Ghabili

Abstract

Methylphenidate, a medication prescribed for individuals suffering from attention-deficit/hyperactivity disorder, is increasingly being misused by students.

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 101 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
France 1 <1%
Canada 1 <1%
Brazil 1 <1%
Unknown 97 96%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 23 23%
Student > Master 10 10%
Student > Doctoral Student 10 10%
Student > Postgraduate 8 8%
Researcher 8 8%
Other 19 19%
Unknown 23 23%
Readers by discipline Count As %
Medicine and Dentistry 47 47%
Nursing and Health Professions 7 7%
Social Sciences 4 4%
Pharmacology, Toxicology and Pharmaceutical Science 4 4%
Agricultural and Biological Sciences 3 3%
Other 8 8%
Unknown 28 28%

Attention Score in Context

This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 March 2017.
All research outputs
#1,930,106
of 17,351,915 outputs
Outputs from Drug Design, Development and Therapy
#79
of 1,713 outputs
Outputs of similar age
#17,932
of 158,160 outputs
Outputs of similar age from Drug Design, Development and Therapy
#3
of 22 outputs
Altmetric has tracked 17,351,915 research outputs across all sources so far. Compared to these this one has done well and is in the 88th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,713 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.1. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 158,160 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 22 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.